New Data Demonstrates Abbott’s Investigational MitraClip(R) System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Condition

First-of-its-Kind, Catheter-Based Device for Mitral Valve Repair Meets Both Primary Safety and Effectiveness Endpoints Compared to Surgery

ATLANTA, March 14, 2010 – Late-breaking data presented today at the American College of
Cardiology's 59th annual scientific session from the landmark EVEREST II
(Endovascular Valve Edge-to-Edge REpair STudy) trial demonstrated that
Abbott's investigational MitraClip(R) system met both its primary safety [...]

Matrix Corporate Capital and PharmaVentures Announce the Signing of a Memorandum of Understanding (MOU)

LONDON and OXFORD, England, March 15, 2010 – Matrix Corporate Capital ("Matrix") and PharmaVentures Limited
("PharmaVentures") today announced the signing of a Memorandum of
Understanding ("MOU") covering strategic transactions in the biotech,
pharmaceutical and med tech sectors. The companies will work together to
identify licensing, buyout, investment, IPO and consolidation opportunities
which bring together both strategic expertise and capital [...]

Abbott Announces Positive Data From ABSORB Trial on Its Bioresorbable Vascular Scaffold Technology

New Data From Second Phase Shows No Blood Clots, No Repeat Procedures and Very Low MACE in Patients Treated with Abbott's Innovative Device

ATLANTA, March 15, 2010 – Abbott (NYSE: ABT) today announced positive 30-day results from the first
101 patients enrolled in the second phase of the ABSORB trial. Patients
treated with Abbott's bioresorbable vascular scaffold [...]

Boston Scientific Announces 1000th European Patient Using LATITUDE(R) Patient Management System

Value of the Service Recognized by Patients and Physicians
PARIS, March 15, 2010 – Boston Scientific Corporation (NYSE: BSX) today announced that
it has reached the milestone of 1000 European patients using its LATITUDE(R)
Patient Management System. The LATITUDE system remotely monitors patients
with implantable cardiac devices, gathering information on both the device
and a patient's heart health status. [...]

New Analysis Suggests Early Initiation of Multaq(R) (dronedarone) Feasible in AF Patients Following Discontinuation of Amiodarone

WYNNEWOOD, Pennsylvania, March 15, 2010 – Data from a post-hoc analysis presented today at the 59th
Annual Scientific Session of the American College of Cardiology in Atlanta,
Georgia, evaluated transition to Multaq(R) (dronedarone) in patients with
atrial fibrillation (AF) or atrial flutter (AFL) following prior treatment
with amiodarone. The data comes from a post-hoc analysis of pooled data [...]

Inadequate Response to Clopidogrel Leads to Higher Incidence of Major Adverse Cardiac Events in Patients Who have Undergone PCI

Results suggest increased need for quantifying patient response to clopidogrel through point-of-care testing

SAN DIEGO, March 15, 2010 – Accumetrics, Inc., a privately-held developer and marketer of the
VerifyNow(R) System, the first rapid and easy-to-use point-of-care system for
measuring platelet reactivity to multiple antiplatelet agents, announced the
presentation of a 2,000 patient meta-analysis examining patient response to
antiplatelet therapy [...]

The Marley Family Announces Partnership With HoMedics to Expand Legacy of Music Legend Bob Marley

Line of Consumer Electronics to Debut in October 2010
CHICAGO, March 15, 2010 – Working together for a better world, reggae musician Bob Marley's Family,
along with HoMedics, introduced The House of Marley in Chicago last night.
Dedicated to benefit people and the planet, The House of Marley is committed
to developing innovative products, adhering to Marley family [...]

Health Robotics Reports Record-Breaking Revenues, EBITDA, Net Profits, and Cash-Flow for its Fiscal Year 2009

BOZEN, Sud-Tirol, Italy, March 15, 2010 – Health Robotics today announced FY2009 results, delivering once again
record levels of revenues, profits and cash flow, overcoming a difficult
global economic climate and the short-term consequences of its decision to
terminate non-performing sales and service channels in North America and
Asia-Pacific.

"We are obviously very proud of [...]

/C O R R E C T I O N – Health Robotics/

BOZEN, Sud-Tirol, Italy, March 15, 2010 – In the news release, "Health Robotics Reports Record-Breaking Revenues,
EBITDA, Net Profits, and Cash-Flow for its Fiscal Year 2009" issued on 15
Mar 2010 13:20 GMT, by Health Robotics over PR Newswire, we are advised by
a representative of the company that "EUR VAR" has been changed to "$ [...]

Healthcare in the Lebanon: Pay Extra Attention Says MediCare International

LONDON, March 15, 2010 -

– The Lebanon is an important centre for international workers
– Post conflict international health cover hard to arrange
– Good hospital facilities can only be accessed with the right cover
– MediCare International offers insurance for [...]

New Board Director Appointed

DUBLIN, March 15, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces the appointment of Bill Burns to its
Board as a Non Executive Director with immediate effect. Mr Burns has also
been appointed a member of Shire's Remuneration Committee.

Mr Burns has a long and distinguished career in [...]

EGE University Hospital in Izmir (Turkey) Establishes Successful VAD Program

BERLIN, March 15, 2010 – Prof. Mustafa ??zbaran, leading surgeon of the VAD program at the EGE
University Hospital in Izmir, implanted for the first time a few days ago the
optimized 3rd generation Berlin Heart INCOR system with its new features. The
surgeon recalls "The implantation went very well, there were no
complications." Two years ago, Prof. [...]

Cheetah Medical Closes $20 Million Series B Financing

Accelerating the Global Commercialization of NICOM(R) Noninvasive Hemodynamic Monitoring Systems

TEL-AVIV, Israel, March 15, 2010 – Cheetah Medical, a worldwide leader in noninvasive hemodynamic and
cardiac output monitoring technology, announced today the closing of a $20
million financing round. The financing was led by Ascension Health Ventures
(AHV) and also included Robert Bosch Venture Capital (RBVC), MVM Life [...]

Only 17% of Children Trust Dad for Advice About Bullying

Bullying a Major Concern for Kids
LONDON, March 15, 2010 – New research out today reveals that while most dads (61%) feel
comfortable giving advice to their children about bullying only 1 in 5 (17%)
children trust their dad's advice on this topic. However 6 out of 10 (59%)
children would trust their mum's advice.

[...]

4-Antibody Announces a Long-Term Collaboration With Boehringer Ingelheim for Therapeutic Antibodies

BASEL, Switzerland, March 16, 2010 – 4-Antibody AG today announces a major long-term collaboration with
Boehringer Ingelheim to discover and to develop fully human therapeutic
antibodies for a number of targets in various disease indications. 4-Antibody
will use its proprietary and unencumbered Hu-PAC(R) and Retrocyte Display(R)
technologies for the discovery and development of fully human antibodies
against novel targets [...]

PERSEUS Trial Results Demonstrate Positive Safety and Efficacy Outcomes for Boston Scientific’s Novel Platinum Chromium TAXUS(R) Element(TM) Stent System

NATICK, Massachusetts and ATLANTA, Georgia, March 16, 2010 – Boston Scientific Corporation (NYSE: BSX) today announced
12-month results from its PERSEUS clinical program that demonstrated positive
safety and efficacy outcomes in workhorse lesions for the platinum chromium
TAXUS(R) Element(TM) Paclitaxel-Eluting Stent System compared to the TAXUS(R)
Express2(TM) Paclitaxel-Eluting Stent System. The results also reported a
similar safety profile and [...]

‘Listen To Your Brain,’ World’s First Neuromarketing Music Video, Launches From NeuroFocus

Four-Minute Production Praised As 'Funnier Than Any Film At South By Southwest'

BERKELEY, California, March 16, 2010 – The tweets flew fast and furious at the famous South By Southwest Music,
Film, & Interactive Festival in Austin, Texas when "Listen To Your Brain"
(www.youtube.com/user/neurofocus#p/a/u/0/RUzo7fhRpFY) began playing on
the big screen.
Created by NeuroFocus, the world's [...]

Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals

DUBLIN, March 16, 2010 – Shire plc (LSE: SHP, NASDAQ; SHPGY), announces that it has received a
Paragraph IV Notice Letter from Teva Pharmaceuticals USA, Inc. ("Teva")
advising of the filing of an Abbreviated New Drug Application ("ANDA") for a
generic version of Shire's 1 mg, 2mg, 3 mg, and 4mg guanfacine hydrochloride
extended release tablets, INTUNIV(TM).

[...]

Ingenuity Systems Announces New Distributor for Greece, Turkey and the Balkans

REDWOOD CITY, California, March 17, 2010 – Ingenuity Systems, the leading provider of information solutions for life
science researchers, has selected Biodiagnostics as its new distributor of
IPA(R) in Greece, Turkey and the Balkan countries. IPA is the leading
software application to model, analyze, and understand the complex biological
and chemical systems at the core of life science [...]

A New Mobile Phone as “Life-insurance” for Millions of Heart Patients

New: a Modern Touch Screen Mobile Phone With an Integrated Electrocardiogram

BERLIN, March 17, 2010 – The H'andy sana 210 mobile phone is a high-quality touch screen mobile
phone with all the functions, such as a camera, MP3 player, file manager,
organizer, additional memory, etc., and that little extra: an integrated
electrocardiogram.
In the UK, [...]

Drug Makers Discuss New Ways to Trim Health Care Costs at ZS Associates and eyeforpharma Forum

Groundbreaking partnerships focused on healthcare value could benefit patients and transform the global healthcare marketplace -

EVANSTON, Illinois, March 17, 2010 – Executives from pharmaceutical companies and health care payer and
provider organizations convened at the "Selling Pharmaceuticals in 2015"
forum in Philadelphia to discuss mutually beneficial partnerships that, if
implemented, could replace the traditional model of selling [...]

Global Partners Join Forces to Speed Development of New TB Drug Combinations

FDA applauds effort to take years off development of much needed TB treatments

WASHINGTON, March 18, 2010 – Ahead of World TB Day, US Food and Drug Administration Commissioner
Margaret Hamburg helped public and private sector partners launch a new
collaboration to significantly accelerate the development of combination
treatments for tuberculosis – and replace an almost 50-year-old drug [...]

Denmark’s Odense University Hospital Works To Make Elekta VMAT Its Mainstream Radiation Therapy Technique

Faster arc-based method could help increase the number of patient treatments per day

ODENSE, Denmark, March 18, 2010 – Odense University Hospital (OUH, Odense, Denmark), a major
multi-specialty medical center serving southern Denmark, joined the global
community of Elekta VMAT
(www.elekta.com/healthcare_international_elekta_vmat.php) clinical
sites last fall when it began treating patients with the arc-based technique.
With Elekta VMAT, single or multiple [...]